Targeted therapies in the treatment of non small cell lung cancer: reality and hopes

被引：6

作者：

Gridelli, C ^{[1
]}

机构：

[1] SG Moscati Hosp, Div Med Oncol, I-83100 Avellino, Italy

来源：

CURRENT OPINION IN ONCOLOGY | 2004年 / 16卷 / 02期

关键词：

D O I：

10.1097/00001622-200403000-00007

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：126 / 129

页数：4

共 15 条

[1]

Ciardiello F, 2001, CLIN CANCER RES, V7, P2958

[2] Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer [J].

Fukuoka, M ;

Yano, S ;

Giaccone, G ;

Tamura, T ;

Nakagawa, K ;

Douillard, JY ;

Nishiwaki, Y ;

Vansteenkiste, J ;

Kudoh, S ;

Rischin, D ;

Eek, R ;

Horai, T ;

Noda, K ;

Takata, I ;

Smit, E ;

Averbuch, S ;

Macleod, A ;

Feyereislova, A ;

Dong, RP ;

Baselga, J .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (12) :2237-2246

[3]

GATZEMEIER U, 2002, P AN M AM SOC CLIN, V21, pA297

[4] Pleural mesothelioma: combined modality treatments [J].

Giaccone, G .

ANNALS OF ONCOLOGY, 2002, 13 :217-225

[5] Gefitinib in elderly and unfit patients affected by advanced non-small-cell lung cancer [J].

Gridelli, C ;

Maione, P ;

Castaldo, V ;

Rossi, A .

BRITISH JOURNAL OF CANCER, 2003, 89 (10) :1827-1829

[6] Treatment of non-small-cell lung cancer: state of the art and development of new biologic agents [J].

Gridelli, C ;

Rossi, A ;

Maione, P .

ONCOGENE, 2003, 22 (42) :6629-6638

[7] How to combine cytotoxic and cytostatic agents [J].

Gridelli, C .

LUNG CANCER, 2002, 38 (01) :S39-S40

[8] Selective cyclooxygenase-2 inhibitors and non-small cell lung cancer [J].

Gridelli, C ;

Maione, P ;

Airoma, G ;

Rossi, A .

CURRENT MEDICINAL CHEMISTRY, 2002, 9 (21) :1851-1858

[9]

JOHNSON DH, 2002, ANN ONCOL, V13, P127

[10]

Johnson DH, 2001, P AN M AM SOC CLIN, V20, p315a

← 1 2 →